JP2008545647A5 - - Google Patents

Download PDF

Info

Publication number
JP2008545647A5
JP2008545647A5 JP2008511788A JP2008511788A JP2008545647A5 JP 2008545647 A5 JP2008545647 A5 JP 2008545647A5 JP 2008511788 A JP2008511788 A JP 2008511788A JP 2008511788 A JP2008511788 A JP 2008511788A JP 2008545647 A5 JP2008545647 A5 JP 2008545647A5
Authority
JP
Japan
Prior art keywords
phenyl
oxo
indolizin
acetamide
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008511788A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008545647A (ja
JP5172661B2 (ja
Filing date
Publication date
Priority claimed from GB0510190A external-priority patent/GB0510190D0/en
Priority claimed from GB0607841A external-priority patent/GB0607841D0/en
Application filed filed Critical
Priority claimed from PCT/GB2006/001820 external-priority patent/WO2006123145A1/en
Publication of JP2008545647A publication Critical patent/JP2008545647A/ja
Publication of JP2008545647A5 publication Critical patent/JP2008545647A5/ja
Application granted granted Critical
Publication of JP5172661B2 publication Critical patent/JP5172661B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2008511788A 2005-05-18 2006-05-18 抗真菌剤 Expired - Fee Related JP5172661B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0510190A GB0510190D0 (en) 2005-05-18 2005-05-18 Antifungal agents
GB0510190.2 2005-05-18
GB0607841.4 2006-04-20
GB0607841A GB0607841D0 (en) 2006-04-20 2006-04-20 Antifungal agents
PCT/GB2006/001820 WO2006123145A1 (en) 2005-05-18 2006-05-18 Antifungal agents

Publications (3)

Publication Number Publication Date
JP2008545647A JP2008545647A (ja) 2008-12-18
JP2008545647A5 true JP2008545647A5 (https=) 2009-07-02
JP5172661B2 JP5172661B2 (ja) 2013-03-27

Family

ID=36763577

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008511788A Expired - Fee Related JP5172661B2 (ja) 2005-05-18 2006-05-18 抗真菌剤

Country Status (11)

Country Link
US (1) US8486962B2 (https=)
EP (1) EP1888063B1 (https=)
JP (1) JP5172661B2 (https=)
AT (1) ATE420639T1 (https=)
AU (1) AU2006248812B2 (https=)
CA (1) CA2608977C (https=)
DE (1) DE602006004865D1 (https=)
DK (1) DK1888063T3 (https=)
ES (1) ES2321230T3 (https=)
NZ (1) NZ563397A (https=)
WO (1) WO2006123145A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0623209D0 (en) * 2006-11-21 2007-01-03 F2G Ltd Antifungal agents
GB0710121D0 (en) * 2007-05-25 2007-07-04 F2G Ltd Antifungal agents
DE102007037579B4 (de) 2007-08-09 2012-05-16 Emc Microcollections Gmbh Neue Benzimidazol-2-yl-alkylamine und ihre Anwendung als mikrobizide Wirkstoffe
CN101168532B (zh) * 2007-11-30 2010-06-02 中科院嘉兴中心应用化学分中心 一种n-甲基哌嗪取代苯胺的合成方法
DK2626361T3 (en) 2008-04-24 2015-01-19 F2G Ltd Pyrrol-Antimycotics
GB0809773D0 (en) * 2008-05-29 2008-07-09 F2G Ltd Antifungal combination therapy
CN103153958A (zh) 2010-07-02 2013-06-12 先正达参股股份有限公司 新颖的杀微生物的二肟醚衍生物
CN103038217A (zh) 2010-07-29 2013-04-10 先正达参股股份有限公司 新颖的杀微生物的二肟醚衍生物
BR112013006671A2 (pt) 2010-09-23 2016-06-07 Syngenta Participations Ag microbiocidas21
WO2012062844A1 (en) 2010-11-12 2012-05-18 Syngenta Participations Ag Novel microbiocides
WO2012117021A2 (en) 2011-03-03 2012-09-07 Syngenta Participations Ag Novel microbiocidal oxime ethers
UY34279A (es) 2011-08-23 2013-04-05 Syngenta Participations Ag Compuestos heterocíclicos activos como microbiocidas, intermediarios, composiciones y usos
WO2013092460A1 (en) 2011-12-20 2013-06-27 Syngenta Participations Ag Cyclic bisoxime microbicides
US20150025105A1 (en) * 2012-02-09 2015-01-22 Praveen Rao Perampalli Nekkar Indolizine derivatives
EP2641901A1 (en) 2012-03-22 2013-09-25 Syngenta Participations AG. Novel microbiocides
CN102964256B (zh) * 2012-11-28 2014-05-07 浙江海翔药业股份有限公司 一种4-氨基-n,n-二甲基苄胺的制备方法
CN104744302A (zh) * 2013-12-31 2015-07-01 上海药谷药业有限公司 一种2-(4-氨基苯基)-2-甲基丙腈化合物的制备方法
CA2982660C (en) * 2014-11-21 2023-01-24 F2G Limited 2-(1,5-dimethyl-3-phenyl-1h-pyrrol-2-yl)-n-(4-(4-(5-fluoropyrimidin-2-yl)piperazine-1-yl)phenyl)-2-oxoacetamide and derivatives thereof for use as antifungal agents
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
CN112898316A (zh) * 2019-12-03 2021-06-04 微境生物医药科技(上海)有限公司 新型吡咯化合物
CN114644634B (zh) * 2020-12-21 2023-06-20 深圳市祥根生物医药有限公司 一种吡咯衍生物及其制备方法和用途
CN114031502A (zh) * 2021-10-09 2022-02-11 南京一苇医药科技有限公司 一种对硝基苯丙酮的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9508298A (pt) 1994-07-21 1998-11-03 Shionogi & Co Inibidores de indolizina de spla2
EP1399442B1 (en) * 2001-06-06 2006-08-09 Vertex Pharmaceuticals Incorporated Cak inhibitors and uses thereof
CA2517034A1 (en) 2003-03-13 2004-09-30 Synta Pharmaceuticals Corp. Fused pyrrole compounds

Similar Documents

Publication Publication Date Title
JP2008545647A5 (https=)
EP1888063B1 (en) Antifungal agents
WO2001052847A1 (en) Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
KR20150080016A (ko) (티오)-카르바모일-시클로헥산 유도체 및 정신분열 치료 방법
BRPI1014174B8 (pt) uso de um composto selecionado a partir de 4-((1s)-1-{[5-cloro-2-(4-fluorofenóxi)benzoil]amino}etil)ácido benzóico, 4-[(1s)-1-({[5-cloro-2-(3-fluorofenóxi)piridin-3-il]carbonil}amino)etil]ácido benzóico e 3-[2-(4-{2-etil-4,6-dimetil-1h-imidazo[4,5-c]piridin-1-il}fenil)etil]-1-[(4-metilbenzeno)sulfonil]urea para tratamento de um câncer epitelial relacionado à pge2
RU2009108275A (ru) Соединение сульфонамида или его соль
JP2019516707A (ja) 繊維筋痛又は繊維筋痛の関連する機能的症候群を予防又は治療するためのカルバメート化合物の使用
ES2300460T3 (es) Combinaciones farmaceuticas sinergicas destinadas a la prevencion o al tratamiento de la diabetes.
JPWO2007132825A1 (ja) 医薬
CN111432814B (zh) 用于减轻或治疗包括脆性X染色体综合征、Angelman综合征或Rett综合征的发育障碍的氨基甲酸酯化合物的用途
WO2005115385A1 (en) Use of c-kit inhibitors for treating acne
WO2018035157A1 (en) Compositions and methods of treating a neurodegenerative disease
TWI583679B (zh) 使用環醯胺衍生物治療精神分裂症之方法
RU2010126842A (ru) Производные пиперазина и их применение в качестве модуляторов рецептора лептина
RU2015101211A (ru) Производное имидазопиридина, используемое для лечения сахарного диабета
CA2657390A1 (en) Use of a p38 kinase inhibitor for treating psychiatric disorders
EP3556366A1 (en) Use of carbamate compounds for prevention, alleviation or treatment of bipolar disorder
RU2751504C2 (ru) Применение карбамата для предупреждения или лечения невралгии тройничного нерва
RU2725112C2 (ru) Способы применения феноксипропиламиновых соединений для лечения депрессии
EP3711758B1 (en) Use of carbamate compound for preventing, alleviating or treating absence seizure or epilepsy showing absence seizure
JP2007518768A (ja) 有機化合物の組み合わせ物
JP2005504029A5 (https=)
RU2774970C2 (ru) Применение карбаматных соединений для профилактики, облегчения или лечения биполярного расстройства
KR20020090152A (ko) 우울증 또는 불안증을 위한 배합 치료